Customers who receive genetic health data not alarmed by results, find information useful

January 11, 2017
Credit: University of Michigan

As consumers have been able to learn more about their genetic makeup in recent years through personal genomic testing, one big criticism has been that without someone to interpret it, the health information could be harmful to the receivers.

Not so, according to a University of Michigan study that shows that less than 2 percent of customers regret receiving such information, and only about 1 percent say they are harmed by the results.

"These data suggest that many of the concerns and criticisms about putting this information into the hands of consumers may presume an exaggerated likelihood of harm," said J. Scott Roberts, associate professor of health behavior and health education at the U-M School of Public Health.

Roberts said that one of the biggest pieces of data consumers were interested in was their ancestry—74 percent of the more than 1,600 participants were very interested in that information. Trait information and data about health risks each were rated as important by 72 percent.

Roberts serves as a principal investigator, along with Robert Green of Brigham & Women's Hospital, on an NIH-funded Impact of Personal Genomics (PGen) Study that measures perceptions and tracks behaviors of individuals who received direct-to-consumer genetic testing from two separate companies prior to FDA restrictions on the information provided to consumers.

The team conducted three web surveys from in 2012 with customers of 23andMe and Pathway Genomics Corp.

The goal of this particular study was to better understand who got tested, and how they perceived the harms, benefits and limitations of the data. Another goal was to examine consumers' decisions to get tested. The survey found that nearly 40 percent did not consider at all the potential for unwanted information.

"This suggests a need for improvement in the informed consent and pretest education process so that appreciate the different types of information they might receive," Roberts said.

After getting results, 59 percent of participants said the information would influence how they managed their health. Heart disease, breast cancer and Alzheimer's were the conditions of greatest interest for genetic risk information, with women and people with poorer self-reported showing high interest in these types of .

In all, 93 percent felt genetic testing was a right decision, and 94 percent said they would do it again.

Explore further: Studies probe value and impact of direct-to-consumer genetic testing

More information: J. Scott Roberts et al. Direct-to-Consumer Genetic Testing: User Motivations, Decision Making, and Perceived Utility of Results, Public Health Genomics (2017). DOI: 10.1159/000455006

Related Stories

Many do not share personal genetic testing results with PCP

March 1, 2016

(HealthDay)—Many individuals who undergo direct-to-consumer (DTC) personal genomic testing (PGT) do not share the results with their primary care provider (PCP), according to research published online March 1 in the Annals ...

Recommended for you

New insights on triggering muscle formation

April 26, 2017

Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a previously unrecognized step in stem cell-mediated muscle regeneration. The study, published in Genes and Development, provides new ...

Risk of obesity influenced by changes in our genes

April 25, 2017

These changes, known as epigenetic modifications, control the activity of our genes without changing the actual DNA sequence. One of the main epigenetic modifications is DNA methylation, which plays a key role in embryonic ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.